Compounding drugs; exceptions for distribution within hospital or health system.
Virginia law now exempts hospitals and health systems from standard pharmaceutical compounding regulations for in-house drug preparation, effective July 1, 2025.
Virginia law now exempts hospitals and health systems from standard pharmaceutical compounding regulations for in-house drug preparation, effective July 1, 2025.
HB 1905 creates exceptions to Virginia's pharmaceutical compounding regulations, allowing hospitals and health systems to compound drugs internally without meeting certain licensing and oversight requirements that typically apply to independent pharmacies. The bill essentially permits in-house drug preparation by hospital pharmacies under their own regulatory framework rather than state pharmacy board standards.
Hospitals argue this streamlines their ability to prepare customized medications for patients with specific needs (like pediatric dosages or allergy accommodations) without regulatory delays. However, it also reduces state-level oversight of drug preparation in institutional settings, which traditionally ensures consistency, safety testing, and quality control standards apply uniformly across all compounding operations.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.